Loading…
Loading…
EQUITY / NYSE · XASE
Milestone Scientific Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.3951 USD · 9.1436%
Observed: Oct 5, 2026, 10:17 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 0.362 USD · Volume 277,476
63 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -1,061,563 USD | -1,484,631 USD | — |
| Net income | -1,059,332 USD | -1,483,110 USD | — |
| Total liabilities | 4,876,921 USD | — | — |
| Total equity | 3,470,877 USD | 3,340,272 USD | +3.91% |
| Gross profit | 1,910,167 USD | 1,617,606 USD | +18.09% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Gross profitIncome statement | 1,910,167 USD | 3,474,191 USD | — | — | 6,407,577 USD | 1,640,870 USD | 4,905,911 USD | 1,617,606 USD |
| Net incomeIncome statement | -1,059,332 USD | -1,899,185 USD | -839,853 USD | — | -5,722,216 USD | -1,153,959 USD | -4,631,655 USD | -1,483,110 USD |
| Operating profitIncome statement | -1,061,563 USD | -1,889,645 USD | — | — | -5,696,617 USD | -1,134,471 USD | -4,616,955 USD | -1,484,631 USD |
| Total assetsBalance sheet | 8,347,798 USD | — | — | 7,806,429 USD | 7,806,429 USD | 8,486,023 USD | — | — |
| Total equityBalance sheet | 3,470,877 USD | — | 2,284,932 USD | 2,812,623 USD | 2,812,623 USD | 2,549,395 USD | — | 3,340,272 USD |
| Total liabilitiesBalance sheet | 4,876,921 USD | — | — | 4,993,806 USD | 4,993,806 USD | 5,936,628 USD | — | — |
| Capital expendituresCash flow statement | — | 5,771 USD | — | — | 15,124 USD | — | 12,008 USD | — |
| Financing cash flowCash flow statement | — | 1,458,184 USD | — | — | 786,335 USD | — | 789,749 USD | — |
| Investing cash flowCash flow statement | — | -5,771 USD | — | — | -15,124 USD | — | -12,008 USD | — |
| Operating cash flowCash flow statement | — | -498,285 USD | — | — | -2,916,627 USD | — | -2,690,498 USD | — |
| Cash and cash equivalentsBalance sheet | — | — | — | — | 1,112,642 USD | 1,345,301 USD | — | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.